Cargando…
Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
OBJECTIVE: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening infectious disease. Treatment requires multiple antimicrobial agents used for extended periods of time. The present study sought to evaluate the treatment success rate of bedaquiline-based regimens in MDR-TB patients. METHODS...
Autores principales: | Hatami, Hossein, Sotgiu, Giovanni, Bostanghadiri, Narjess, Abadi, Sahel Shafiee Dolat, Mesgarpour, Bita, Goudarzi, Hossein, Migliori, Giovanni Battista, Nasiri, Mohammad Javad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836629/ https://www.ncbi.nlm.nih.gov/pubmed/35649043 http://dx.doi.org/10.36416/1806-3756/e20210384 |
Ejemplares similares
-
Amikacin liposome and Mycobacterium avium complex: A systematic review
por: Zangiabadian, Moein, et al.
Publicado: (2022) -
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017) -
Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019) -
Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!
por: Tiberi, Simon, et al.
Publicado: (2018) -
Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)